Svb Wealth LLC Ligand Pharmaceuticals Inc Transaction History
Svb Wealth LLC
- $2.41 Billion
- Q1 2025
A detailed history of Svb Wealth LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Svb Wealth LLC holds 23 shares of LGND stock, worth $3,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$3,451% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
286Shares Held
18.9MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$431 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$308 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$154 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$136 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$112 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.53B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...